3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Motor Activity
1
Lymphoma
1
Leukemia
1
Interventions
Cyclophosphamide
12
Specimen Handling
11
Biopsy
11
Rituximab
9
Magnetic Resonance Spectroscopy
9
Prednisone
7
obinutuzumab
6
fludarabine
6
Lenalidomide
6
pembrolizumab
5
Nuclear Medicine Department, Hospital
5
Doxorubicin
5
X-Rays
4
venetoclax
3
fludarabine phosphate
3
Vincristine
3
Tacrolimus
3
Nivolumab
3
Mycophenolic Acid
3
GSK2636771
3
Etoposide
3
Busulfan
3
Bendamustine Hydrochloride
3
trametinib
2
tocilizumab
2
palbociclib
2
osimertinib
2
ipatasertib
2
ibrutinib
2
glofitamab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma
×
Isoproterenol
×
30 days
×
Clear all
NCT06643221
2026-06-05
Allo-X
University of Arizona
Phase EARLY_PHASE1
Recruiting
200 enrolled